Oppenheimer Initiates Coverage on Aquestive Therapeutics (NASDAQ:AQST)
Research analysts at Oppenheimer started coverage on shares of Aquestive Therapeutics (NASDAQ:AQST – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $7.00 price target on the stock. Oppenheimer’s price objective would indicate a potential upside of 120.13% from […]
Research analysts at Oppenheimer started coverage on shares of Aquestive Therapeutics (NASDAQ:AQST – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $7.00 price target on the stock. Oppenheimer’s price objective would indicate a potential upside of 120.13% from […]
